Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung carcinoma
Authors Eric T Wong, Julian K Wu, Anand Mahadevan
Published 15 January 2008 Volume 2007:1(3) Pages 321—324
Eric T Wong1,2, Julian K Wu2,3, Anand Mahadevan2,4
1Department of Neurology, 2Brain Tumor Center and Neuro-Oncology Unit, 3Division of Neurosurgery, and 4Department of Radiation Oncology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
Abstract: Carcinomatous encephalitis is a rapidly fatal form of metastasis caused by miliary spread of systemic cancer into the brain parenchyma. The diagnostic criteria and optimal treatment for this disease are not well defined. We report a patient with rapid neurologic deterioration from carcinomatous encephalitis from lung adenocarcinoma. She was treated with gefitinib and high-dose fractionated whole brain radiotherapy, and eventually improved neurologically and was discharged home on hospital day 48. Gefitinib and high-dose fractionated radiotherapy may have synergistic activity in patients with carcinomatous encephalitis from non-small cell lung cancer having favorable prognostic factors. More importantly, timely recognition of this disease and the use of large fraction radiation therapy are necessary to control rapid neurologic deterioration.
Keywords: brain metastases, Gefitinib, radiation